electroCore, Inc. (ECOR)

[MinnieM]

This article gives good rationale on why non-invasive Neuromodulation might help in covid. It's 3rd party. None of the researchers are affiliated with ECOR. I think the non invasive info starts on page 14.

Neuromodulation and Inflammatory Reflex: Perspectives on the Use of Non-Invasive Neuromodulation in the Management of Disorders Related to COVID-19
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3601048

Use the above link to download the pdf. It's free.

Highlights
? An extensive review of the literature in relation to the impact of COVID-19 on the central and peripheral nervous system, with emphasis on the discussion of the noninvasive
neuromodulation potential in the management of symptoms of COVID.
? Globally, this work points to a yet unexplored safe technique that presents a reasonable potential to emerge as another resource among the scarce options to deal with the disease.

There are 26 trials listed on clinicaltrials.gov. Of those, the company is listed as a sponsor for 21 of them. There are two covid trials listed and they both are scheduled for completion this year.

https://clinicaltrials.gov/ct2/results?cond=&term=gammacore&cntry=&state=&city=&dist=

Clinical trials are a good use of funds... I didn't expect this many.

*****

Ownership forms: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001560258&type=&dateb=&owner=only&count=40&search_text=

*****

They filed an S-3 on 5.27.20 and the notice of effect was filed on 6.2.20

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001560258&type=&dateb=&owner=exclude&count=40&search_text=

S-3 gives outstanding as of 5.20.20: 38,130,275 shares.
https://www.sec.gov/Archives/edgar/data/1560258/000119312520153058/d899602ds3.htm